System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Johan Gagnière is an expert in Surgery at Centre Hospitalier Universitaire de Clermont-Ferrand (France). Johan Gagnière has authored 169 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 4 of them ongoing. SLR score: 498 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Johan Gagnière Centre Hospitalier Universitaire de Clermont-Ferrand France
498 ScienceLeadR Reputation 498

Unlock

Register Login
Network Map

Surgery

Subspecialties: Oncology - Gastroenterology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

University of Clermont Auvergne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 169

Citations

Citations: 4 088 1st author: 19 Last author: 16 Unique author: 1

Main journals

Ann Surg Oncol 17
Eur J Surg Oncol 15
Ann Surg 11
HPB (Oxford) 8
J Visc Surg 6

Best Journals

J Clin Oncol 2
JAMA Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Textbook Outcomes and Survival in Gastric Cancer Surgery: Results of a French-Speaking Multicenter Study.
PMID 42746996 — achievement, disease-free survival, neoplasms, therapeutics, stomach neoplasms		World J Surg20260
Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohort.
PMID 42414185 — liver diseases, mortality, blood, operative time, morbidity, pancreatectomy		HPB (Oxford)20260
Choledochoduodenostomy versus transpapillary stent by endoscopic retrograde cholangiopancreatography for preoperative biliary drainage before pancreatoduodenectomy: a French multicenter retrospective cohort study.
PMID 42257926 — cholangiopancreatography, endoscopic retrograde, drainage, stents, mortality, disease-free survival, pancreaticoduodenectomy, cohort studies, endoscopy, morbidity		Surg Endosc20260
Predicting Best Performers After Minimally Invasive Left Pancreatectomy: Insights From a National Cohort.
PMID 42237086 — mortality, minimally invasive surgical procedures, reoperation, general surgery, pancreatectomy		Ann Surg20260
International practice patterns and perceptions of pressurised intraperitoneal aerosol chemotherapy for management of gastric cancer: A global clinician survey.
PMID 42173034 — aerosols, neoplasms, perception, drug therapy, therapeutics, medical oncology, stomach neoplasms, chemotherapy		Eur J Surg Oncol20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Director: 1

By phase:

N/A 10
Phase 3 2
Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 4
Unknown 4
Recruiting 3
Not yet recruiting 2
Terminated 1

By type:

Interventional 8
Observational 6

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 1
multicentric5to9 0
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
PRODIGE 87 FOXTROT II Personalising and refining neo adjuvant chemotherapy in locally advanced but resectable colon cancer in the elderly of 70 years old or more
2023-505214-23-00 — neoplasms, colon, drug therapy, aged, chemotherapy, adjuvant, colonic neoplasms, chemotherapy, carcinoma		Phase 3Recruiting2024
Risk adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with FOLFIRINOX FRENCH26 PRODIGE93 PANACHE02 Trial
2024-519048-33-00 — adenocarcinoma, drug therapy, chemotherapy, adjuvant, therapeutics, chemotherapy		Phase 2/Phase 3Recruiting2025
Chemotherapy in the Context of Esophageal and Gastroesophageal Junction Cancer Cachexia
NCT05954117 — anesthesia, general, anesthesia, subcutaneous fat, abdominal, muscles, subcutaneous fat, esophagus, esophagogastric junction, neoplasms, adenocarcinoma, mitochondria, biopsy, drug therapy, adipocytes, operative time, muscle strength, therapeutics, tissues, cachexia, adipose tissue, chemotherapy, cancer-associated cachexia		N/ANot yet recruiting2023
PAncreas Borderline and Locally Advanced Snapshot Study
NCT05470738 — pancreatic neoplasms, neoplasms, adenocarcinoma, pancreas		N/ANot yet recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS